Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire • 5 days agoXeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients lives by developing and commercializing innovative products across a range...